[1]
Jamison RN, Mao J. Opioid Analgesics. Mayo Clinic proceedings. 2015 Jul:90(7):957-68. doi: 10.1016/j.mayocp.2015.04.010. Epub
[PubMed PMID: 26141334]
[2]
Camilleri M, Lembo A, Katzka DA. Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2017 Sep:15(9):1338-1349. doi: 10.1016/j.cgh.2017.05.014. Epub 2017 May 19
[PubMed PMID: 28529168]
[3]
Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain physician. 2008 Mar:11(2 Suppl):S105-20
[PubMed PMID: 18443635]
[4]
Vora A, Nadkar MY. Codeine: A Relook at the Old Antitussive. The Journal of the Association of Physicians of India. 2015 Apr:63(4):80, 82-5
[PubMed PMID: 26591180]
[5]
Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, Calixto F, Bolden JL, Urman RD, Manchikanti L. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain physician. 2017 Feb:20(2S):S93-S109
[PubMed PMID: 28226333]
[6]
Volkow ND, McLellan AT. Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. The New England journal of medicine. 2016 Mar 31:374(13):1253-63. doi: 10.1056/NEJMra1507771. Epub
[PubMed PMID: 27028915]
[7]
Rancu AL, Salib A, Kammien AJ, Lizardi JJ, Allam O, Grauer JN, Alperovich M. Opioid Use Following Open Reduction and Internal Fixation of Mandibular Fractures. The Journal of craniofacial surgery. 2024 Nov 27:():. doi: 10.1097/SCS.0000000000010930. Epub 2024 Nov 27
[PubMed PMID: 39601551]
[8]
Heinz A, Gutwinski S, Krausz M, Ernst G, Vogel M, Scherbaum N. [Challenges in the treatment of opioid dependence]. Der Nervenarzt. 2024 Sep:95(9):811-817. doi: 10.1007/s00115-024-01691-9. Epub 2024 Jul 15
[PubMed PMID: 39008087]
[9]
Jones GH, Bruera E, Abdi S, Kantarjian HM. The opioid epidemic in the United States-Overview, origins, and potential solutions. Cancer. 2018 Nov 15:124(22):4279-4286. doi: 10.1002/cncr.31713. Epub 2018 Oct 9
[PubMed PMID: 30299538]
Level 3 (low-level) evidence
[10]
Pacitti C, Cairns D, Ward L, Nicholl BI. Investigating pain-related medication use and contribution to polypharmacy in adults with intellectual disabilities: a systematic review. BMC medicine. 2024 Dec 2:22(1):565. doi: 10.1186/s12916-024-03770-9. Epub 2024 Dec 2
[PubMed PMID: 39617875]
Level 1 (high-level) evidence
[11]
Lasong J, Salifu Y, Kakungu JAWM. Prevalence and factors associated with tramadol use among university students in Ghana: a cross-sectional survey. BMC psychiatry. 2024 Nov 27:24(1):853. doi: 10.1186/s12888-024-06230-z. Epub 2024 Nov 27
[PubMed PMID: 39604896]
Level 2 (mid-level) evidence
[12]
Raffa RB. On subclasses of opioid analgesics. Current medical research and opinion. 2014 Dec:30(12):2579-84. doi: 10.1185/03007995.2014.952717. Epub 2014 Sep 23
[PubMed PMID: 25105308]
Level 3 (low-level) evidence
[13]
Yönder H, Toprak K, Berhuni MS, Elkan H, Tatlı F, Özgönül A, Yüksekyayla B, Koyuncu H, Taşcanov MB, Fedai H, Ocak M, Arğa Y, Uzunköy A. The Relationship Between Tramadol Use and Cardio Electrophysiological Balance for Postoperative Pain Treatment in General Surgery Patients. Medicina (Kaunas, Lithuania). 2024 Oct 22:60(11):. doi: 10.3390/medicina60111731. Epub 2024 Oct 22
[PubMed PMID: 39596916]
[14]
Chung KF. Clinical cough VI: the need for new therapies for cough: disease-specific and symptom-related antitussives. Handbook of experimental pharmacology. 2009:(187):343-68. doi: 10.1007/978-3-540-79842-2_18. Epub
[PubMed PMID: 18825350]
[15]
Green JL, Bucher Bartelson B, Le Lait MC, Roland CL, Masters ET, Mardekian J, Bailey JE, Dart RC. Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration. Drug and alcohol dependence. 2017 Jun 1:175():140-145. doi: 10.1016/j.drugalcdep.2017.01.039. Epub 2017 Mar 28
[PubMed PMID: 28414990]
[16]
Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S, American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019 Jan:156(1):218-226. doi: 10.1053/j.gastro.2018.07.016. Epub 2018 Oct 16
[PubMed PMID: 30340754]
[17]
Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and Treatment of Opioid Misuse and Addiction: A Review. JAMA psychiatry. 2019 Feb 1:76(2):208-216. doi: 10.1001/jamapsychiatry.2018.3126. Epub
[PubMed PMID: 30516809]
[18]
Skeer MR, Hajinazarian G, Sabelli RA, Yang J, Chui K, Booth M, Robison E, Boyadjian T, Stopka TJ. 'Once that's worn off, we could discuss whether you need more': provider perspectives on communicating with patients and other providers about prescription opioids. Journal of communication in healthcare. 2024 Dec 2:():1-10. doi: 10.1080/17538068.2024.2431772. Epub 2024 Dec 2
[PubMed PMID: 39620704]
Level 3 (low-level) evidence
[19]
Shukimbayeva A, Prilutskaya M, Mansurova J. Cardiac manifestations of post-acute withdrawal syndrome from a history of synthetic cathinone and opioid use. The Medical journal of Malaysia. 2024 Nov:79(6):703-707
[PubMed PMID: 39614787]
[20]
Rodríguez-Espinosa S, Coloma-Carmona A, Pérez-Carbonell A, Román-Quiles JF, Carballo JL. Tolerance, interdose withdrawal symptoms, and craving predict prescription opioid-use disorder severity in chronic pain patients: A three-wave prospective study. Psychiatry research. 2024 Dec:342():116241. doi: 10.1016/j.psychres.2024.116241. Epub 2024 Oct 21
[PubMed PMID: 39476453]
[21]
Guillet C, Endomba FT, Aravantinos D, Hussami A, Beye F, Girod JC, Georges M, Aho Glélé LS. Sleep apnea syndrome in patients with methadone or buprenorphine. L'Encephale. 2024 Nov 6:():. pii: S0013-7006(24)00195-7. doi: 10.1016/j.encep.2024.07.003. Epub 2024 Nov 6
[PubMed PMID: 39510877]
[22]
Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The Opioid Epidemic in the United States. Emergency medicine clinics of North America. 2016 May:34(2):e1-e23. doi: 10.1016/j.emc.2015.11.002. Epub 2016 Feb 17
[PubMed PMID: 27133253]
[23]
Harris C, Roy PJ, Mitchell AM, Anderson MW. Improving Linkage for Patients With Injection-Drug-Use-Related Endocarditis and Osteomyelitis to Medications for Opioid Use Disorder Through a Telephone Intervention. Journal of addictions nursing. 2024 Jul-Sep 01:35(3):132-136. doi: 10.1097/JAN.0000000000000585. Epub
[PubMed PMID: 39356584]
[24]
El-Dalati S, Alnabelsi T, Gurley J, Cremeans K, Reda H, London-Bounds T, Ogburn E, Sekela M. Acute drug-use-related native tricuspid valve infective endocarditis: a non-surgical disease. Therapeutic advances in infectious disease. 2024 Jan-Dec:11():20499361241267124. doi: 10.1177/20499361241267124. Epub 2024 Aug 7
[PubMed PMID: 39132095]
Level 3 (low-level) evidence
[25]
Saroya J, Singh A, Chang JL, Durr ML. Opioid Prescription Trends Among Sleep Surgeons in the United States. The Laryngoscope. 2024 Nov:134(11):4810-4817. doi: 10.1002/lary.31543. Epub 2024 Jun 15
[PubMed PMID: 38877817]
[26]
Smallwood NE, Pascoe A, Wijsenbeek M, Russell AM, Holland AE, Romero L, Ekström M. Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis. European respiratory review : an official journal of the European Respiratory Society. 2024 Oct:33(174):. doi: 10.1183/16000617.0265-2023. Epub 2024 Oct 9
[PubMed PMID: 39384304]
Level 1 (high-level) evidence
[27]
Izrailtyan I, Qiu J, Overdyk FJ, Erslon M, Gan TJ. Risk factors for cardiopulmonary and respiratory arrest in medical and surgical hospital patients on opioid analgesics and sedatives. PloS one. 2018:13(3):e0194553. doi: 10.1371/journal.pone.0194553. Epub 2018 Mar 22
[PubMed PMID: 29566020]
Level 2 (mid-level) evidence
[28]
Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, Cooper WO. Increasing pregnancy-related use of prescribed opioid analgesics. Annals of epidemiology. 2013 Aug:23(8):498-503. doi: 10.1016/j.annepidem.2013.05.017. Epub
[PubMed PMID: 23889859]
[29]
Kwong TC, Magnani B, Moore C. Urine and oral fluid drug testing in support of pain management. Critical reviews in clinical laboratory sciences. 2017 Sep:54(6):433-445. doi: 10.1080/10408363.2017.1385053. Epub 2017 Oct 9
[PubMed PMID: 28990451]
[30]
Heller GZ, Manuguerra M, Chow R. How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance. Scandinavian journal of pain. 2016 Oct:13():67-75. doi: 10.1016/j.sjpain.2016.06.012. Epub 2016 Jul 27
[PubMed PMID: 28850536]
[31]
Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). Journal of psychoactive drugs. 2003 Apr-Jun:35(2):253-9
[PubMed PMID: 12924748]
[32]
Ryan SA, Dunne RB. Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. Pain management. 2018 May:8(3):231-245. doi: 10.2217/pmt-2017-0060. Epub 2018 Apr 23
[PubMed PMID: 29683378]
Level 1 (high-level) evidence
[33]
Lindner S, Hart K, Manibusan B, Johnston KA, McCarty D, McConnell KJ. Effects Of Medicaid Waivers On Use Of Medications For Opioid Use Disorder And Nonfatal Overdoses In 17 States. Health affairs (Project Hope). 2024 Nov:43(11):1597-1604. doi: 10.1377/hlthaff.2024.00461. Epub
[PubMed PMID: 39496087]
[34]
Armour R, Nielsen S, Buxton JA, Bolster J, Han MX, Ross L. Initiation of buprenorphine in the emergency department or emergency out-of-hospital setting: A mixed-methods systematic review. The American journal of emergency medicine. 2024 Nov 17:88():12-22. doi: 10.1016/j.ajem.2024.11.031. Epub 2024 Nov 17
[PubMed PMID: 39577213]
Level 1 (high-level) evidence
[35]
Aboujaoude E, Salame WO. Naltrexone: A Pan-Addiction Treatment? CNS drugs. 2016 Aug:30(8):719-33. doi: 10.1007/s40263-016-0373-0. Epub
[PubMed PMID: 27401883]
[36]
Baker DW. Improving Pain Management and Safe Use of Opioids: A Call for Papers. Joint Commission journal on quality and patient safety. 2017 Sep:43(9):492. doi: 10.1016/j.jcjq.2017.07.001. Epub 2017 Jul 24
[PubMed PMID: 28844235]
Level 2 (mid-level) evidence
[37]
Sato T, Fukutomi A, Kawamura T, Kawakami K, Sato T, Kamo Y, Suzuki T, Hagiya S, Tanaka R. Low-dose add-on methadone for cancer pain management: a retrospective analysis of 102 Japanese patients. Japanese journal of clinical oncology. 2024 Nov 5:():. pii: hyae156. doi: 10.1093/jjco/hyae156. Epub 2024 Nov 5
[PubMed PMID: 39498764]
Level 2 (mid-level) evidence
[38]
Guzman RA, Ammons J, Westberg J, Schmidt A. Implementation of a Patient-Specific Opioid Taper Calculator for Total Hip and Knee Arthroplasty: A Pre-Post Study. The Journal of arthroplasty. 2024 Nov 29:():. pii: S0883-5403(24)01253-1. doi: 10.1016/j.arth.2024.11.040. Epub 2024 Nov 29
[PubMed PMID: 39617272]
[39]
Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, Murphy LB, Dowell D. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015. MMWR. Morbidity and mortality weekly report. 2017 Jul 7:66(26):697-704. doi: 10.15585/mmwr.mm6626a4. Epub 2017 Jul 7
[PubMed PMID: 28683056]
[40]
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19:315(15):1624-45. doi: 10.1001/jama.2016.1464. Epub
[PubMed PMID: 26977696]
[41]
Lim JK, Bratberg JP, Davis CS, Green TC, Walley AY. Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. Journal of addiction medicine. 2016 Sep-Oct:10(5):300-8. doi: 10.1097/ADM.0000000000000223. Epub
[PubMed PMID: 27261669]
[42]
Kuehn BM. FDA opioid safety plan promotes patient, physician education to prevent abuse. JAMA. 2010 Aug 25:304(8):845. doi: 10.1001/jama.2010.1200. Epub
[PubMed PMID: 20736462]
[43]
Cepeda MS, Coplan PM, Kopper NW, Maziere JY, Wedin GP, Wallace LE. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes. Pain medicine (Malden, Mass.). 2017 Jan 1:18(1):78-85. doi: 10.1093/pm/pnw129. Epub
[PubMed PMID: 27373304]
Level 3 (low-level) evidence